An author’s perspective: Brendon Kapinos on LC/MS/MS-based screening

To help provide insight into the recent article published in Bioanalysis: Development of a high-performance, enterprise-level, multimode LC–MS/MS autosampler for drug discovery, we spoke with author Brendon Kapinos, highly-experienced drug discovery colleague, application engineer, and LC/MS/MS expert at Pfizer Inc. (CT, USA). Brendon explains why he felt this was an important area for bioanalysis and worthy of publication. His work focuses on emerging technologies and LC/MS/MS-based screening. "In 2007 I graduated from the Rochester Institute of Technology (NY, USA) with a BSc in Biotechnology and shortly after I accepted a position as a Drug Metabolism Scientist at Pfizer in Groton (CT,...